Stocks and Investing Stocks and Investing
Fri, August 13, 2021

Scott Henry Maintained (VVOS) at Strong Buy with Decreased Target to $250 on, Aug 13th, 2021


Published on 2024-10-27 17:38:44 - WOPRAI, Scott Henry
  Print publication without navigation


Scott Henry of Roth Capital, Maintained "Vivos Therapeutics, Inc." (VVOS) at Strong Buy with Decreased Target from $275 to $250 on, Aug 13th, 2021.

Scott, nor any peers, have made any analyst calls on VVOS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources